CAMP4 Therapeutics Preprints Pioneering Study on Regulatory RNA Profiling and Gene Upregulation
Using epigenomic mapping and regulatory RNA (regRNA) Capture-seq, CAMP4 has assembled what it believes to be the largest catalog of...
Using epigenomic mapping and regulatory RNA (regRNA) Capture-seq, CAMP4 has assembled what it believes to be the largest catalog of...
Buntanetap improved cognition in pTau217-positive early AD patientsThe drug reduced neurotoxic proteins as well as biomarkers of neuroinflammation and neurodegenerationBuntanetap...
BURLINGAME, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Biomolecular Holdings LLC, a privately-held biotechnology company advancing next-generation antibody architectures, today...
Agreement facilitates flexible, scalable automated industrialized production of rese-cel for many thousands of patients per year at a cost per...
Kestrel has entered into a warrant agreement with AbbVie with an exclusive option for AbbVie to acquire the Company based...
New AI capabilities create a feedback loop where analyst input and automated analysis continuously improve threat detection and response BOSTON,...
- Orphan drug designation from the European Commission underscores Solid’s commitment to advance SGT-003 through a global development effort for...
SUNNYVALE, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- BioCardia®, Inc. , a global leader in cellular and cell-derived therapeutics for the...
SEATTLE, April 28, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform,...
High-quality pediatric care is growing in Georgia, North Carolina, Pennsylvania, and TennesseeNASHVILLE, Tenn., April 28, 2026 (GLOBE NEWSWIRE) -- Playground...
ATLANTA, April 28, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team...
Expands access by 6 million covered lives, advancing commercial momentum for CNSide® in metastatic CNS cancersHOUSTON, April 28, 2026 (GLOBE...
– ARCALYST® (rilonacept) Q1 2026 net product revenue of $214.3 million, representing 56% year-over-year growth –– ARCALYST 2026 expected net...
With recent FDA acceptance of the Phase 2a multidose portion of INLIGHT trial of WVE-007 (INHBE GalNAc-siRNA) in individuals with higher...
SOUTH SAN FRANCISCO, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced nine presentations at the...
- New national campaign encourages recognition of ATTR-CM, often mistaken for other heart conditions, where earlier diagnosis and treatment may...
Collaboration with leading mental health organization to support HLP003 Phase 3 recruitment and expand outreach in veteran communities following landmark...
HOLLISTON, Mass., April 28, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the...
Vancouver, British Columbia--(Newsfile Corp. - April 28, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF)...
London, United Kingdom--(Newsfile Corp. - April 28, 2026) - Edison issues report on Halyk Bank (LSE: HSBK).Halyk Bank offers a...